[1] ZHI Dongli LIU Huan HE Wei HU Yangcheng XU Yan,.Targeting AK1,CYP1B1,and MGAM with Maxing Shigan Decoction for Treatment of Community Acquired Pneumonia in Children [J]. Modern Traditional Chinese Medicine, 2023, (04): 83-90.
Targeting AK1,CYP1B1,and MGAM with Maxing Shigan Decoction for Treatment of Community Acquired Pneumonia in Children
- Article number:
- 1672-0571(2023)04-0083-08
- Keywords:
- Key words:Maxing Shigan decoction; Treatment; Community acquired pneumonia; Network pharmacology; Transcriptome
- ZTFLH:
- R246.4
- Code:
- A
- Abstract:
- Abstract：Objective To elucidate the main target of Maxing Shigan decoction in the treatment of children's community acquired pneumonia through Transcriptome analysis combined with network pharmacology and experimental verification methods.Methods R 3.5.0 were analyzed and plotted using limma,factoextra,dplyr,tible,tidyr,and ggplot2 packages.The components and targets of Maxing Shigan decoction were obtained using TCMSP,TCMID,and PharmaMapper databases.Using Elisa for IL-6 and TNF-α Detection and Western Blot detection of AK1,CYP1B1,and MGAM.Results There were 335 differentially expressed genes between the community acquired pneumonia group and the control group;Maxing Shigan decoction can reduce the inflammatory damage of A549 cells;Maxing Shigan decoction can increase the level of AK1,reduce the levels of CYP1B1 and MGAM,and thus play a role in regulating community acquired pneumonia.Conclusion Maxing Shigan decoction can regulate the targets and inflammation levels related to community acquired pneumonia.
References:
[1]王亚翠,吴喜蓉,刘芳,等.2016年至2019年北京住院儿童肺炎支原体感染流行病学特征和耐药性[J].中华实用儿科临床杂志,2022,37(14)：1082-1085.
[2]林婉靖,邵雪君,张钧,等.接种13价肺炎球菌结合疫苗对就诊儿童肺炎链球菌血清型和耐药性的影响[J].中华疾病控制杂志,2022,26(5)：565-570.
[3]徐炎,孔一卜,杨福双, 等.天然产物抑制肺炎链球菌研究进展[J].吉林中医药,2020,40(7)：871-874.
[4]谢铱子,纪树亮,詹少锋,等.麻杏石甘汤治疗慢性阻塞性肺疾病急性加重期的文献分析及试验序贯分析[J].中国中医基础医学杂志,2022,28(6) ：909-918.
[5]任晓婷,徐炎,孙丽平.麻杏石甘汤现代研究进展及展望[J].吉林中医药,2020,40(8)：1106-1109.
[6]徐炎,孔一卜,韩晶,等.基于网络药理学麻黄治疗肺炎的作用机制研究[J].中华中医药学刊,2021,39(1)：66-72,274.
[7]Ru JL,Li P,Wang JN,et al.TCMSP：a database of systems pharmacology for drug discovery from herbal medicines[J].Journal of Cheminformatics,2014,6(1)：13.
[8]Yao Y,Zhang XD,Wang ZZ,et al.Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-Huang Decoction[J].Journal of Ethnopharmacology,2013,150(2)：619-638.
[9]耿胜男,谢鹏,李阳杰,等.基于网络药理学的麻杏石甘汤治疗支气管哮喘的作用机制分析[J].药物评价研究,2020,43(11)：2168-2175.
[10]Guo TT,Guo YN,Liu QB,et al.The TCM prescription Ma-Xing-Shi-Gan-Tang inhibits Streptococcus pneumoniae pathogenesis by targeting pneumolysin[J].Journal of Ethnopharmacology,2021,275：114133.
[11]Xu Y,Wei LN,Wang YB,et al.Inhibitory effect of the traditional Chinese medicine Ephedra sinica granules on Streptococcus pneumoniae pneumolysin[J].Biological & Pharmaceutical Bulletin,2020,43(6)：994-999.
[12]薛守宇,朱涛,李冰冰,等.转录组和代谢组联合分析在植物中的应用研究[J].山西农业大学学报(自然科学版),2022,42(3)：1-13.
[13]何倚涟.转录组和代谢组联合分析柴胡皂苷合成通路研究[D].绵阳：西南科技大学,2022.
[14]苏钺凯.基于多组学解析丹参根色形成及丹参酮生物合成调控研究[D].泰安：山东农业大学,2022.
[15]刘卓航,董少忠.全转录组测序在临床医学上的应用[J].中国生物制品学杂志,2022,35(6)：748-751.
[16]申凤霞,范建伟,李倩,等.基于网络药理学及分子对接探究茵栀黄颗粒治疗肝纤维化的作用机制[J].山东科学,2023,36(1)：23-33.
[17]刘运仲,闫庆峰,潘松利,等.B型胸腺瘤组织IL-1、IL-6及EBER-1基因表达与EBV感染的关系[J].中华医院感染学杂志,2022,32(15)：2314-2318.
[18]常学辉,陈帅杰,张良芝,等.龟羚帕安丸对PD大鼠血清IL-6、IL-1β、TNF-α、Hcy、UA及APN水平的影响[J/OL].中华中医药学刊：1-9[2023-05-05].http：//kns.cnki.net/kcms/detail/21.1546.r.20220722.1236.048.html.
[19]喻欣,赵云,吕玉霞,等.脐带血IL-6和IL-10基因多态性及其血清水平与早产儿感染的关联[J].中华医院感染学杂志,2022,32(13)：2076-2080.
[20]Xie MY,Zhang GF,Zhang HB,et al.Adenylate kinase 1 deficiency disrupts mouse sperm motility under conditions of energy stress[J].Biology of Reproduction,2020,103(5)：1121-1131.
[21]Zervou S,McAndrew DJ,Whittington HJ,et al.Subtle role for adenylate kinase 1 in maintaining normal basal contractile function and metabolism in the murine heart[J].Frontiers in Physiology,2021,12：623969.
[22]Panayiotou C,Solaroli N,Karlsson A.The many isoforms of human adenylate kinases[J].The International Journal of Biochemistry & Cell Biology,2014,49：75-83.
[23]张雷,王林,耿智敏,等.肝癌细胞转移与PI3K-Akt-PAK1通路的相关性研究[J].实用肝脏病杂志,2017,20(3)：307-311.
[24]Morvan VL,Richard ,Cadars M,et al.Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma[J].British Journal of Cancer,2020,123(5)：772-784.
[25]赵丽华,刘小聪,冯婧,等.CYP1B1在成年肥胖小鼠巨噬细胞浸润及组织炎症中的作用[J].营养学报,2012,34(3)：242-244,249.
[26]刘胜先,杜文静,崔宝程,等.Comamonas testosteroni 5-MGAM-4D来源的腈水合酶基因重组菌对腈类化合物的全细胞催化活性[J].食品工业科技,2020,41(24)：94-99.
Memo
基金项目：国家自然科学基金项目（82205190）